Haleema Shakur Still

So having people like Abiola and local people was a massive, massive lesson for me.

She took us into the community.

I was lucky enough to spend time with her and members of Ward C a few months ago.

And we went out into the community and things as a Westerner, I will be very reserved about doing.

Abiola went into the marketplace with a microphone and called all the women and asked them questions

in their own language and talked to them in their own language and discussed postpartum hemorrhage and discussed the life-saving benefits of tranexamic acid.

All of these things I would never have been able to do.

or known how to do.

So we cannot understate the importance of having local voices telling local stories and people taking ownership.

And she's absolutely right because Nigeria in the first woman trial recruited over 5,000 women and had most of the women who died

that contributed to knowledge that's been used around the world came from Nigeria.

So ownership should be with the women of Nigeria.

So that's something, the fact that Watsi and Dr. Abiola has taken on, I'm incredibly proud of.

The Woman 2 trial was looking at whether we can prevent postpartum hemorrhage happening in the first place in women with anemia.

We thought that giving tranexamic acid to prevent postpartum hemorrhage happening

in the first place was a good idea.

Because if you can stop women bleeding, they're not going to die from bleeding.

And it's one of these situations, as a scientist, you're supposed to go in with a neutral hypothesis.

This is one situation I did not go in with the neutral.

No, but the thing is, it's why you do trials.